Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro.
OBJECTIVE
Biliary epithelial cells are targets of immune-mediated attack in conditions such as primary biliary cirrhosis and allograft rejection. This has been attributed to the ability of biliary epithelial cells to express ligands for T cell receptors. We aimed to investigate the expression of immune recognition elements and the effects of pro-inflammatory and anti-inflammatory cytokines on cell surface phenotypes of normal human biliary epithelial cells and established human liver-derived (PLC/PRF/5, HepG2, Hep3B and CC-SW) lines.


METHODS
Cells were cultured in the presence or absence of cytokines for 72 h, and expression of cell surface molecules was assessed by flow cytometry and immunofluorescence.


RESULTS
All cell lines expressed MHC class I, ICAM-1 (CD54), LFA-3 (CD58) and EGF receptor, and all but Hep3B expressed Fas/Apo-1 (CD95). Unlike hepatocyte-derived cell lines, biliary epithelial cells and CC-SW expressed CD40 and CD44. As expected, IFNgamma and TNFalpha upregulated expression of ICAM-1, MHC class I and MHC class II, particularly in biliary epithelial cells. TGFbeta downregulated these molecules and downregulated CD95 on biliary epithelial cells, but upregulated LFA-3. The Th2 cytokines had little effect, although IL-4 upregulated CD95 expression on biliary epithelial cells. IFNgamma upregulated CD40 expression on biliary epithelial cells, CC-SW and HepG2.


CONCLUSIONS
These findings imply that biliary epithelial cells may be capable of interacting with activated T lymphocytes via CD40 and LFA-3, which are thought to be important T cell accessory ligands for T cell activation in a B7-independent manner. Sensitivity to pro-inflammatory cytokines and expression of CD95 may explain why biliary epithelial cells are primary targets for autoimmune attack.
Cruickshank
S M
SM
ICRF Cancer Medicine Research Unit, Research School of Medicine, St. James's University Hospital, Leeds, UK.
Southgate
J
J
Selby
P J
PJ
Trejdosiewicz
L K
LK
D001653:Bile Ducts, Intrahepatic / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D019013:CD40 Antigens / Q000032:analysis; D002460:Cell Line; D016207:Cytokines / Q000494:pharmacology*; D004847:Epithelial Cells / Q000276:immunology; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D007633:Keratins / Q000032:analysis; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000276:immunology*
D019013:CD40 Antigens; D016207:Cytokines; D006684:HLA-DR Antigens; D018960:Hyaluronan Receptors; D007633:Keratins